Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets.

Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie. Medicinal product subject to medical prescription.

Please contact Clonmel Healthcare on 01-6204000 if you require any additional information.

PA 126/356/1-3. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: July 2023. 2023/ADV/RAN/154H.

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets

BOOTS IRELAND LAUNCHES NEW LIVER SCANNING SERVICE

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

ALONE Urges Government to Reconsider Pharmacy Changes Including Blister Packs

Migraine Ireland Launches First Multidisciplinary Irish Headache Society

Boots Ireland Unveils Groundbreaking Common Conditions Service, Empowering Pharmacists to Prescribe for the First Time

RECOMMENDED NEWS

CPD – Importance of Vitamin D

McCabes Pharmacy Announced as Exclusive Pharmacy Partner to Athletics Ireland and Title Sponsor of “Fit for Life” Programme

The Baby Boom

Overview and Risk Factors for Crohn’s Disease

test-sponsored-ad-jan-2026

Quick links

Other info